Pfizer & MPP Sign Deal For Generics Of COVID-19 Candidate Paxlovid
Tiered Pricing To Allow Equitable Access
An agreement allowing the production and distribution of the US firm’s new protease inhibitor in 95 countries has been welcomed by the Medicines Patent Pool. But some medicines access advocates are not so sure it’s necessarily a good deal for lower-income countries.
